Lycopene reduces mortality in people with systemic lupus erythematosus: A pilot study based on the third national health and nutrition examination survey

Journal of Dermatological Treatment

Volumn 27, Issue 5, 2016, Pages 430-435

  Han, Guang Ming ^a,b,c   Han, Xiao Feng ^a  

^a JIANGNAN UNIVERSITY   (China)

^b Nebraska Department of Health and Human Services   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

cardiovascular disease and mortality; lycopene; Systemic lupus erythematosus

Indexed keywords

ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTITHYROID AGENT; CARDIOVASCULAR AGENT; CORTICOSTEROID; ESTROGEN; GESTAGEN; LYCOPENE; NONSTEROID ANTIINFLAMMATORY AGENT; RESPIRATORY TRACT AGENT; THYROID HORMONE; CAROTENOID;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DRUG POTENCY; FEMALE; HEALTH SURVEY; HUMAN; MALE; MORTALITY; MORTALITY RATE; NUTRITIONAL HEALTH; PILOT STUDY; PRIORITY JOURNAL; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASE; MIDDLE AGED; NUTRITION;

ADULT; CARDIOVASCULAR DISEASES; CAROTENOIDS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NUTRITION SURVEYS; PILOT PROJECTS;

EID: 84954216136     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2015.1133879     Document Type: Article

References (28)

1. M.Merrell, L.E.Shulman Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J Chronic Dis. 1955;1:12–32.
2. J.Trager, M.M.Ward Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol. 2001;13:345–51.
3. E.Ruiz, E.Ramalle-Gómara, Á.Elena,. Trends in systemic lupus erythematosus mortality in Spain from 1981 to 2010. Lupus. 2014;23:431–5.
4. G.Thomas, J.Mancini, N.Jourde-Chiche,. Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis. Arthritis Rheumatol. 2014;66:2503–11.
5. M.Yurkovich, K.Vostretsova, W.Chen, J.A.Aviña-Zubieta Overall and cause-specific mortality in patients with systemic lupus erythematosus:a meta-analysis of observational studies. Arthritis Care Res (Hoboken). 2014;66:608–16.
6. J.M.Kahlenberg, M.J.Kaplan The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus. Arthritis Res Ther. 2011;13:203. doi:10.1186/ar3264.
7. S.L.Nuttall, S.Heaton, M.K.Piper,. Cardiovascular risk in systemic lupus erythematosus-evidence of increased oxidative stress and dyslipidaemia. Rheumatology (Oxford). 2003;42:758–62.
8. N.E.Moran, J.W.ErdmanJr, S.K.Clinton Complex interactions between dietary and genetic factors impact lycopene metabolism and distribution. Arch Biochem Biophys. 2013;539:171–80.
9. A.Ateşşahin, A.O.Ceribaşi, S.Yilmaz Lycopene, a carotenoid, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rats. Basic Clin Pharmacol Toxicol. 2007;100:372–6.
10. M.M.Ali, F.G.Agha Amelioration of streptozotocin-induced diabetes mellitus, oxidative stress and dyslipidemia in rats by tomato extract lycopene. Scand J Clin Lab Invest. 2009;69:371–9.
11. C.W.Hadley, S.K.Clinton, S.J.Schwartz The consumption of processed tomato products enhances plasma lycopene concentrations in association with a reduced lipoprotein sensitivity to oxidative damage. J Nutr. 2003;133:727–32.
12. S.Devaraj, S.Mathur, A.Basu,. A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress. J Am Coll Nutr. 2008;27:267–73.
13. E.Gouranton, C.Thabuis, C.Riollet,. Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue. J Nutr Biochem. 2011;22:642–8.
14. A.Luvizotto Rde, A.F.Nascimento, E.Imaizumi,. Lycopene supplementation modulates plasma concentrations and epididymal adipose tissue mRNA of leptin, resistin and IL-6 in diet-induced obese rats. Br J Nutr. 2013;110:1803–9.
15. L.Kohlmeier, J.D.Kark, E.Gomez-Gracia,. Lycopene and myocardial infarction risk in the EURAMIC Study. Am J Epidemiol. 1997;146:618–26.
16. J.Karppi, J.A.Laukkanen, T.H.Mäkikallio, S.Kurl Low serum lycopene and β-carotene increase risk of acute myocardial infarction in men. Eur J Public Health. 2012;22:835–40.
17. M.Bobak, H.W.Hense, J.Kark,. An ecological study of determinants of coronary heart disease rates:a comparison of Czech, Bavarian and Israeli men. Int J Epidemiol. 1999;28:437–44.
18. T.H.Rissanen, S.Voutilainen, K.Nyyssönen,. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke:the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr. 2001;85:749–54.
19. M.Kristenson, B.Ziedén, Z.Kucinskienë,. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men:concomitant cross sectional study of men aged 50. BMJ. 1997;314:629–33.
20. Y.Ito, M.Kurata, K.Suzuki,. Cardiovascular disease mortality and serum carotenoid levels:a Japanese population-based follow-up study. J Epidemiol. 2006;16:154–60.
21. I.Komiya, T.Yamada, N.Takasu,. An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system. J Hypertens. 1997;15:65–72.
22. G.E.Eroglu, P.F.Kohler Familial systemic lupus erythematosus:the role of genetic and environmental factors. Ann Rheum Dis. 2002;61:29–31.
23. M.Petri Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2002;16:847–58.
24. E.Svenungsson, G.Z.Fei, K.Jensen-Urstad,. TNF-alpha:a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease. Lupus. 2003;12:454–61.
25. M.A.Omair, V.Phumethum, S.R.Johnson Long-term safety and effectiveness of tumour necrosis factor inhibitors in systemic sclerosis patients with inflammatory arthritis. Clin Exp Rheumatol. 2012;30:S55–9.
26. J.Marcotorchino, B.Romier, E.Gouranton,. Lycopene attenuates LPS-induced TNF-α secretion in macrophages and inflammatory markers in adipocytes exposed to macrophage-conditioned media. Mol Nutr Food Res. 2012;56:725–32.
27. D.T.Pierine, M.E.Navarro, I.O.Minatel,. Lycopene supplementation reduces TNF-α via RAGE in the kidney of obese rats. Nutr Diabetes. 2014;4:e142.
28. P.R.Gajendragadkar, A.Hubsch, K.M.Mäki-Petäjä,. Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers:a randomised controlled trial. PLoS One. 2014;9:e99070.